Association of pulmonary hypertension-targeted therapy and survival in precapillary pulmonary hypertension with mean pulmonary arterial pressure between 21 and 24 mmHg.

Summary: Doctors have recently redefined pulmonary hypertension (high blood pressure in the lungs) to include milder cases that were previously overlooked. A new study using a large international registry looked at 132 patients with this "mild" form of the disease (pressures slightly elevated at 21–24 mmHg). Researchers compared those who received specific lung medications—mostly standard pills like phosphodiesterase-5 inhibitors—against those who did not. The results were striking: patients who received treatment lived significantly longer than those who didn't, even though the treated group started with more kidney problems and oxygen needs. This suggests that starting treatment early, even for mild cases, could be a lifesaver, though more testing is needed to confirm these findings.